| scholarly article | Q13442814 |
| P356 | DOI | 10.1196/ANNALS.1408.009 |
| P8608 | Fatcat ID | release_46gxp423w5fmxmy4xopetcp6y4 |
| P698 | PubMed publication ID | 17470916 |
| P5875 | ResearchGate publication ID | 6359005 |
| P2093 | author name string | Robert Boehm | |
| P2860 | cites work | Production of antibodies in transgenic plants | Q46882065 |
| Apoplastic and cytosolic expression of full-size antibodies and antibody fragments in Nicotiana tabacum | Q47249899 | ||
| Process and economic evaluation of the extraction and purification of recombinant beta-glucuronidase from transgenic corn | Q47725493 | ||
| Stable integration and functional expression of flounder growth hormone gene in transformed microalga, Chlorella ellipsoidea | Q51039019 | ||
| Production and secretion of biologically active human granulocyte-macrophage colony stimulating factor in transgenic tomato suspension cultures | Q51809066 | ||
| Chloroplast transformation in oilseed rape | Q52604344 | ||
| Expression of non-toxic mutant of Escherichia coli heat-labile enterotoxin in tobacco chloroplasts | Q54497923 | ||
| Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans | Q55883944 | ||
| Rice cell culture as an alternative production system for functional diagnostic and therapeutic antibodies | Q57523324 | ||
| Over-expressing a yeast ornithine decarboxylase gene in transgenic roots of Nicotiana rustica can lead to enhanced nicotine accumulation | Q67260871 | ||
| Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum | Q68385511 | ||
| Expression and purification of functional human alpha-1-Antitrypsin from cultured plant cells | Q73422956 | ||
| Expression and Characterization of Bryodin 1 and a Bryodin 1-Based Single-Chain Immunotoxin from Tobacco Cell Culture | Q73778020 | ||
| Expression and characterization of bispecific single-chain Fv fragments produced in transgenic plants | Q78016471 | ||
| Technical Advance: Stable chloroplast transformation in potato: use of green fluorescent protein as a plastid marker | Q78216302 | ||
| Expression and secretion of the heterodimeric protein interleukin-12 in plant cell suspension culture | Q78854792 | ||
| A simple and general method for transferring genes into plants | Q80958729 | ||
| Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants | Q30320231 | ||
| Towards molecular farming in the future: using plant-cell-suspension cultures as bioreactors. | Q33747507 | ||
| Towards molecular farming in the future: transient protein expression in plants. | Q33747516 | ||
| A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii | Q33873205 | ||
| Foreign protein production in plant tissue cultures | Q33884974 | ||
| Oral immunization with hepatitis B surface antigen expressed in transgenic plants | Q33944696 | ||
| Transgenic plants as factories for biopharmaceuticals | Q34076132 | ||
| Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit | Q34089082 | ||
| Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants | Q34240349 | ||
| The production of recombinant pharmaceutical proteins in plants. | Q34267406 | ||
| Transgenic plastids in basic research and plant biotechnology | Q34374099 | ||
| Plantibodies: applications, advantages and bottlenecks | Q34598066 | ||
| Plant cell factories and mucosal vaccines | Q35121947 | ||
| Plant-based vaccines | Q35143262 | ||
| Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves | Q35640308 | ||
| The moss bioreactor | Q35683396 | ||
| New advances in the production of edible plant vaccines: chloroplast expression of a tetanus vaccine antigen, TetC. | Q35757152 | ||
| Plant cell cultures for the production of recombinant proteins | Q35940957 | ||
| Heterologous protein production using the Pichia pastoris expression system. | Q36036987 | ||
| Chloroplast-derived vaccine antigens and other therapeutic proteins | Q36055964 | ||
| Recent developments in the production of human therapeutic proteins in eukaryotic algae | Q36065964 | ||
| Sowing the seeds of success: pharmaceutical proteins from plants. | Q36098498 | ||
| Stable transformation of the cotton plastid genome and maternal inheritance of transgenes | Q36349426 | ||
| Expression of hepatitis B surface antigen in transgenic plants | Q37337644 | ||
| Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition | Q37339930 | ||
| Characterization of monoclonal antibody fragments produced by plant cells | Q43587177 | ||
| Expression of recombinant human acetylcholinesterase in transgenic tomato plants. | Q43759333 | ||
| Generation of fertile transplastomic soybean. | Q45190600 | ||
| Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses | Q45507304 | ||
| Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast | Q45722406 | ||
| Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1. | Q45746533 | ||
| A plant-derived edible vaccine against hepatitis B virus. | Q45746962 | ||
| A cyclical semicontinuous process for production of human alpha 1-antitrypsin using metabolically induced plant cell suspension cultures | Q46413921 | ||
| Plant cell culture for production of paclitaxel and other taxanes | Q46760002 | ||
| The production of transgenic potato plants expressing human alpha-interferon using lipofectin-mediated transformation. | Q46875793 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 121-134 | |
| P577 | publication date | 2007-04-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms | |
| P478 | volume | 1102 |
| Q33385000 | A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65). |
| Q33737666 | Amyloid-like protein inclusions in tobacco transgenic plants |
| Q36328854 | An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice |
| Q37955649 | Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives |
| Q53329382 | Do microRNAs play a role in the activity of plant-based vaccines? |
| Q42859399 | Evaluation of alternatives for human lysozyme purification from transgenic rice: Impact of phytic acid and buffer |
| Q34534970 | Expression and Subcellular Targeting of Human Complement Factor C5a in Nicotiana species |
| Q35661423 | Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens. |
| Q36591189 | Expression of a ricin toxin B subunit: insulin fusion protein in edible plant tissues |
| Q53030473 | Expression of cholera toxin B subunit-lumbrokinase in edible sunflower seeds-the use of transmucosal carrier to enhance its fusion protein's effect on protection of rats and mice against thrombosis |
| Q47738620 | Generation of plant-derived recombinant DTP subunit vaccine |
| Q54356469 | Hairy roots cultures from different Solanaceous species have varying capacities to produce E. coli B-subunit heat-labile toxin antigen |
| Q50574557 | High-yield expression of recombinant soybean agglutinin in plants using transient and stable systems |
| Q38995002 | Inhibition of protease activity by antisense RNA improves recombinant protein production in Nicotiana tabacum cv. Bright Yellow 2 (BY-2) suspension cells |
| Q34565122 | Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro |
| Q38058462 | Molecular Strategies to Engineer Transgenic Rice Seed Compartments for Large-Scale Production of Plant-Made Pharmaceuticals |
| Q34744742 | Molecular factors affecting the accumulation of recombinant proteins in the Chlamydomonas reinhardtii chloroplast |
| Q38043582 | Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins |
| Q41202282 | Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells |
| Q37776718 | Plant-derived vaccines and other therapeutics produced in contained systems |
| Q37776723 | Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we? |
| Q34018403 | Plants as bioreactors: Recent developments and emerging opportunities |
| Q36655994 | Production of pharmaceutical proteins in solanaceae food crops |
| Q84620578 | Production of recombinant human granulocyte macrophage‐colony stimulating factor in rice cell suspension culture with a human‐like N‐glycan structure |
| Q35784729 | Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules |
| Q83012994 | Recombinant Protein Expression in Nicotiana |
| Q36327788 | Stable plastid transformation for high-level recombinant protein expression: promises and challenges. |
| Q91709459 | The case for biotech on Mars |
| Q50525791 | The development, characterization, and demonstration of a novel strategy for purification of recombinant proteins expressed in plants |
| Q38239254 | The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins. |
| Q37828731 | Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures |
| Q81828667 | Transgenic tomato expressing interleukin-12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis |
Search more.